Upgrade to SI Premium - Free Trial

Moderna (MRNA) Shares Plunge 13% on EPS and Revenue Miss and Slashed Covid-19 Vaccine Sales Guidance

November 4, 2021 8:31 AM
Shares of Moderna (NASDAQ: MRNA) are down more than 13% in pre-open Thursday after the company delivered disappointing Q3 results ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments Earnings Guidance Hot Earnings Hot Guidance

Next Articles